Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...

A widely used medicine for diabetes and weight loss is now raising new concerns among scientists. The drug, called semaglutide, has become very popular in recent years. It is commonly sold under brand ...

For patients, a new diagnosis of diabetes can be overwhelming. It means not only managing blood sugar but also preventing serious future health complications such as diabetic retinal disease, a ...

The Gazette offers audio versions of articles using Instaread. Some words may be mispronounced. This story first appeared in Healthy You - November 2024, The Gazette’s quarterly health publication.

Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...

Share on Pinterest New research links GLP-1 medications such as semaglutide and tirzepatide to a doubled risk of potentially blinding eye diseases. Javier Zayas Photography/Getty Images The most ...

Type 2 diabetes is among the top causes of vision loss and blindness across the world. According to studies, visual impairment due to diabetic retinopathy has increased significantly in the last 20 ...

You may find yourself experiencing small changes in your health that seem easy to dismiss, yet these early discomforts often carry a deeper message about what is happening inside your body. Diabetes ...

"Interventions should include automated electronic health record prompts; point-of-care screening methods, such as teleophthalmology integration; additional care coordination resources; and targeted ...